Bibliography
- Vyas SP, Gupta PN. Implication of nanoparticles/microparticles in mucosal vaccine delivery. Expert Rev Vaccines 2007;6(3):401-18
- Matthys H. Definition and assessment of asthma. Lung 1990;168(Suppl):51-6
- Foxwell AR, Cripps AW, Kyd JM. Optimization of oral immunization through receptor-mediated targeting of M cells. Hum Vaccin 2007;3(5):220-3
- Holmgren J, Czerkinsky C, Eriksson K, Mharandi A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 2003;21(Suppl 2):S89-95
- Enose Y, Ui M, Miyake A, et al. Protection by intranasal immunization of a nef-deleted, nonpathogenic SHIV against intravaginal challenge with a heterologous pathogenic SHIV. Virology 2002;298(2):306-16
- Sabin AB. Strategies for elimination of poliomyelitis in different parts of the world with use of oral poliovirus vaccine. Rev infect Dis 1984;6(Suppl 2):S391-6
- Man AL, Prieto-Garcia ME, Nicoletti C. Improving M cell mediated transport across mucosal barriers: do certain bacteria hold the keys? Immunology 2004;113(1):15-22
- Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006;6(2):148-58
- Frossard CP, Tropia L, Hauser C, Eigenmann PA. Lymphocytes in Peyer patches regulate clinical tolerance in a murine model of food allergy. J Allergy Clin Immunol 2004;113(5):958-64
- Brayden DJ, Jepson MA, Baird AW. Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting. Drug Discov Today 2005;10(17):1145-57
- Owen RL, Jones AL. Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology 1974;66(2):189-203
- Owen RL. Sequential uptake of horseradish peroxidase by lymphoid follicle epithelium of Peyer's patches in the normal unobstructed mouse intestine: an ultrastructural study. Gastroenterology 1977;72(3):440-51
- Kaiserlian D, Etchart N. Entry sites for oral vaccines and drugs: A role for M cells, enterocytes and dendritic cells? Semin immunol 1999;11(3):217-24
- Jang MH, Kweon MN, Iwatani K, et al. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc Natl Acad Sci USA 2004;101(16):6110-5
- Frey A, Giannasca KT, Weltzin R, et al. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med 1996;184(3):1045-59
- Neutra MR, Frey A, Kraehenbuhl JP. Epithelial M cells: gateways for mucosal infection and immunization. Cell 1996;86(3):345-8
- Tyrer PC, Ruth Foxwell A, Kyd JM, et al. Receptor mediated targeting of M-cells. Vaccine 2007;25(16):3204-9
- Meynell HM, Thomas NW, James PS, et al. Up-regulation of microsphere transport across the follicle-associated epithelium of Peyer's patch by exposure to Streptococcus pneumoniae R36a. FASEB J 1999;13(6):611-9
- Gebert A, Steinmetz I, Fassbender S, Wendlandt KH. Antigen transport into Peyer's patches: increased uptake by constant numbers of M cells. Am J Pathol 2004;164(1):65-72
- Baumler AJ, Tsolis RM, Heffron F. The lpf fimbrial operon mediates adhesion of Salmonella typhimurium to murine Peyer's patches. Proc Natl Acad Sci USA 1996;93(1):279-83
- Clark MA, Hirst BH, Jepson MA. M-cell surface beta1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells. Infect Immun 1998;66(3):1237-43
- Cryz SJ Jr, Vanprapar N, Thisyakorn U, et al. Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children. Infect Immun 1993;61(3):1149-51
- Suzuki T, Yoshikawa Y, Ashida H, et al. High vaccine efficacy against shigellosis of recombinant noninvasive Shigella mutant that expresses Yersinia invasin. J Immunol 2006;177(7):4709-17
- Londono-Arcila P, Freeman D, Kleanthous H, et al. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen. Infect Immun 2002;70(9):5096-106
- Stokes MG, Titball RW, Neeson BN, et al. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis. Infect Immun 2007;75(4):1827-34
- Crotty S, Miller CJ, Lohman BL, et al. Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors. J Virol 2001;75(16):7435-52
- Clark MA, Jepson MA, Hirst BH. Exploiting M cells for drug and vaccine delivery. Adv Drug Deliv Rev 2001;50(1-2):81-106
- Jani P, Halbert GW, Langridge J, Florence AT. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol 1990;42(12):821-6
- Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 1996;13(12):1838-45
- McNeela EA, Mills KH. Manipulating the immune system: humoral versus cell-mediated immunity. Adv Drug Deliv Rev 2001;51(1-3):43-54
- Tracy MA, Ward KL, Firouzabadian L, et al. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro Biomaterials 1999;20(11):1057-62
- Allison AG, Gregoriadis G. Liposomes as immunological adjuvants. Nature 1974;252(5480):252
- Schulte R, Kerneis S, Klinke S, et al. Translocation of Yersinia entrocolitica across reconstituted intestinal epithelial monolayers is triggered by Yersinia invasin binding to beta1 integrins apically expressed on M-like cells. Cell Microbiol 2000;2(2):173-85
- Hussain N, Florence AT. Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles. Pharm Res 1998;15(1):153-6
- Tyrer P, Ruth Foxwell A, Kyd J, et al. Validation and quantitation of an in vitro M-cell model. Biochem Biophys Res Commun 2002;299(3):377-83
- Gullberg E, Keita AV, Salim SY, et al. Identification of cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the Peyer's patches. J Pharm Exp Ther 2006;319(2):632-9
- Garinot M, Fievez V, Pourcelle V, et al. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J Control Release 2007;120(3):195-204
- Smith MW, Thomas NW, Jenkins PG, et al. Selective transport of microparticles across Peyer's patch follicle-associated M cells from mice and rats. Exp physiol 1995;80(5):735-43
- Zhou F, Kraehenbuhl JP, Neutra MR. Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes. Vaccine 1995;13(7):637-44
- Mantis NJ, Cheung MC, Chintalacharuvu KR, et al. Selective adherence of IgA to murine Peyer's patch M cells: evidence for a novel IgA receptor. J Immunol 2002;169(4):1844-51
- Pappo J, Ermak TH, Steger HJ. Monoclonal antibody-directed targeting of fluorescent polystyrene microspheres to Peyer's patch M cells. Immunology 1991;73(3):277-80
- Nochi T, Yuki Y, Matsumura A, et al. A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J Exp Med 2007;204(12):2789-96
- Sharma R, van Damme EJ, Peumans WJ, et al. Lectin binding reveals divergent carbohydrate expression in human and mouse Peyer's patches. Histochem cell Biol 1996;105(6):459-65
- Clark MA, Jepson MA, Hirst BH. Lectin binding defines and differentiates M-cells in mouse small intestine and caecum. HistocheM cell Biol 1995;104(2):161-8
- Hathaway LJ, Kraehenbuhl JP. The role of M cells in mucosal immunity. Cell Mol Life Sci 2000;57(2):323-32
- Clark MA, Jepson MA, Simmons NL, et al. Differential expression of lectin-binding sites defines mouse intestinal M-cells. J Histochem Cytochem 1993;41(11):1679-87
- Clark MA, Jepson MA, Simmons NL, Hirst BH. Selective binding and transcytosis of Ulex europaeus 1 lectin by mouse Peyer's patch M-cells in vivo Cell Tissue Res 1995;282(3):455-61
- Foster N, Clark MA, Jepson MA, Hirst BH. Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo. Vaccine 1998;16(5):536-41
- Chen H, Torchilin V, Langer R. Lectin-bearing polymerized liposomes as potential oral vaccine carriers. Pharm Res 1996;13(9):1378-83
- Clark MA, Blair H, Liang L, et al. Targeting polymerised liposome vaccine carriers to intestinal M cells. Vaccine 2001;20(1-2):208-17
- Gupta PN, Khatri K, Goyal AK, et al. M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B. J Drug Target 2007;15(10):701-13
- Giannasca PJ, Giannasca KT, Leichtner AM, Neutra MR. Human intestinal M cells display the sialyl Lewis A antigen. Infect Immun 1999;67(2):946-53
- Lambkin I, Pinilla C, Hamashin C, et al. Toward targeted oral vaccine delivery systems: selection of lectin mimetics from combinatorial libraries. Pharm Res 2003;20(8):1258-66
- Wong NA, Herriot M, Rae F. An immunohistochemical study and review of potential markers of human intestinal M cells. Eur J Histochem 2003;47(2):143-50
- Pielage JF, Cichon C, Greune L, et al. Reversible differentiation of Caco-2 cells reveals galectin-9 as a surface marker molecule for human follicle-associated epithelia and M cell-like cells. Int J Biochem cell Biol 2007;39(10):1886-901
- Almeida AJ, Alpar HO. Nasal delivery of vaccines. J Drug Target 1996;3(6):455-67
- Cremaschi D, Porta C, Ghirardelli R. Different kinds of polypeptides and polypeptide-coated nanoparticles are accepted by the selective transcytosis shown in the rabbit nasal mucosa. Biochim Biophys Acta 1999;1416(1-2):31-8
- Jeong KI, Uetsuka K, Nakayama H, Doi K. Glycoconjugate expression in follicle-associated epithelium (FAE) covering the nasal-associated lymphoid tissue (NALT) in specific pathogen-free and conventional rats. Exp Anim 1999;48(1):23-29
- Giannasca PJ, Boden JA, Monath TP. Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins. Infect Immun 1997;65(10):4288-98
- Wu Y, Wang X, Csencsits KL, et al. M cell-targeted DNA vaccination. Proc Natl Acad Sci USA 2001;98(16):9318-23
- Manocha M, Pal PC, Chitralekha KT, et al. Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target. Vaccine 2005;23(48-49):5599-617
- Tabata Y, Inoue Y, Ikada Y. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. Vaccine 1996;14(17-18):1677-85
- Nakase H, Okazaki K, Tabata Y, et al. Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy. J Pharm Exp Ther 2000;292(1):15-21
- Roth-Walter F, Bohle B, Scholl I, et al. Targeting antigens to murine and human M-cells with Aleuria aurantia lectin-functionalized microparticles. Immunol Lett 2005;100(2):182-8
- Kerneis S, Bogdanova A, Kraehenbuhl JP, Pringault E. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 1997;277(5328):949-52
- Jensen VB, Harty JT, Jones BD. Interactions of the invasive pathogens Salmonella typhimurium, Listeria monocytogenes, and Shigella flexneri with M cells and murine Peyer's patches. Infect Immun 1998;66(8):3758-66
- Ando T, Hatsushika K, Wako M, et al. Orally administered TGF-beta is biologically active in the intestinal mucosa and enhances oral tolerance. J Allergy Clin Immunol 2007;120(4):916-23